| Approximate equivalent dose* (mg) | Relative glucocorticoid activity | Relative mineralocorticoid activity | Duration of action (hours) | General therapeutic indications |
---|---|---|---|---|---|
Glucocorticoids | |||||
Short-acting | Â | Â | Â | Â | Â |
 Hydrocortisone | 20 | 1 | 1 | 8-12 | • Relatively high mineralocorticoid activity makes it suitable for use in adrenal insufficiency |
 Cortisone | 25 | 0.8 | 0.8 | 8-12 | • Similar to hydrocortisone |
Intermediate-acting | Â | Â | Â | Â | Â |
 Prednisone | 5 | 4 | 0.8 | 12-36 | • High glucocorticoid activity makes it useful for long-term treatment, and as an anti-inflammatory/ immunosuppressant |
 Prednisolone | 5 | 4 | 0.8 | 12-36 | • Similar to prednisone |
Methylprednisolone | 4 | 5 | Minimal | 12-36 | • Anti-inflammatory/immunosuppressant |
 Triamcinolone | 4 | 5 | 0 | 12-36 | • Anti-inflammatory/immunosuppressant |
Long-acting | |||||
 Dexamethasone | 0.75 | 30 | Minimal | 36-72 | • Anti-inflammatory/immunosuppressant; used especially when water retention is undesirable given its minimal mineralocorticoid activity |
• Usually reserved for short-term use in severe, acute conditions given its high potency and long-duration of action | |||||
 Betamethasone | 0.6 | 30 | Negligible | 36-72 | • Similar to dexamethasone |
Mineralocorticoids | |||||
 Fludrocortisone | ** | 10-15 | 125-150 | 12-36 | • Used for aldosterone replacement |